OCCPI: Pelotonia-Funded Research Saves Lives of At-Risk Family Members

James McDaniel’s colon cancer diagnosis came as no surprise. His father, uncle and grandfather all succumbed to the disease in their mid-40s. Read More

James McDaniel’s colon cancer diagnosis came as no surprise. His father, uncle and grandfather all succumbed to the disease in their mid-40s. “I’d been expecting it,” says McDaniel, who was age 48 at the time of his diagnosis. A vice president of the mortgage division at Huntington and father of three daughters, McDaniel had been cleared during his cancer screening at age 44 and told to come back for another screening in five years - but that was prior to the discovery that he has Lynch syndrome, an inherited genetic condition that predisposes individuals to colorectal and uterine cancer. Read More

Lynch Syndrome: The Cancer Connection Uncovered [INFOGRAPHIC]

Researchers at the OSUCCC – James discovered just how big of an impact genetic variations can have on an individual’s cancer detection, prevention, treatment and cure. Read More

There is no routine cancer, and researchers at the OSUCCC – James discovered just how big of an impact genetic variations can have on an individual’s cancer detection, prevention, treatment and cure when they found a direct relationship between the presence of Lynch syndrome and colorectal cancer in patients. This discovery led to a pioneering of screening efforts to increase years of life for those affected with LS. Read More

Ovarian Cancer & the Lynch Syndrome Link

Can medical experts really predict if a woman will get ovarian or uterine/endometrial cancer? In many cases, yes – they really can. Read More

Can medical experts really predict if a woman will get ovarian or uterine/endometrial cancer? In many cases, yes – they really can. An inherited genetic condition called Lynch syndrome is actually the most common cause of hereditary uterine cancer, and it also increases the risk of ovarian cancer. The syndrome is passed down from generation to generation, predisposing these women not only to gynecologic cancers, but to colon and other cancers as well. Read More

4 Things to Know About BRCA Cancer Risk and Genetic Testing

On June 13, 2013, the United States Supreme Court ruled that naturally occurring DNA cannot be subject to patent. What does this mean for you? Read More

On June 13, 2013, the United States Supreme Court ruled that naturally occurring DNA cannot be subject to patent.What does this mean for you? Because there is no routine cancer, it is crucial to study an individual’s genetic makeup. Now, physicians and other healthcare providers can offer more high-quality, affordable options to study your genetics and assess cancer risk, including genetic tests for BRCA1 and BRCA2 gene mutations. Read More

4 Things to Know About BRCA Cancer Risk and Genetic Testing

On June 13, 2013, the United States Supreme Court ruled that naturally occurring DNA cannot be subject to patent. What does this mean for you? Read More

On June 13, 2013, the United States Supreme Court ruled that naturally occurring DNA cannot be subject to patent.What does this mean for you? Because there is no routine cancer, it is crucial to study an individual’s genetic makeup. Now, physicians and other healthcare providers can offer more high-quality, affordable options to study your genetics and assess cancer risk, including genetic tests for BRCA1 and BRCA2 gene mutations. Read More

Genetic Testing: What Consumers Need to Know

Imagine taking a guided tour of your own DNA – the biological roadmap on any number of pathways that could lead to specific illnesses. Read More

Imagine taking a guided tour of your own DNA – the biological roadmap on any number of pathways that could lead to specific illnesses. Medical experts have actually been doing it for years, studying genes and identifying risk factors and precursors for a number of diseases, including cancer. And the studies and testing are getting even more sophisticated with each passing year. Read More